Key Points
India's drug pricing regulator is considering capping prices of vital medicines like vitamin A, vitamin C, glycerine and anti-tetanus immunoglobulin to curb profiteering by the pharmaceutical companies...
The National Pharmaceutical Pricing Authority (NPPA) proposes to invoke extraordinary powers in public interest, under para 19 of Drugs Prices Control Order (DPCO) 2013, for an indefinite period to make them more affordable to patients, it has said...
"The NPPA has been invoking para 19 in certain cases in the public interest to make drugs affordable with indefinite period," said the minutes of the authority meeting..
According to All India Organisation of Chemists and Druggists (AIOCD), the rapid increase in the number of Covid-19 cases pushed the demand for immunity boosters like vitamin tablets by 30%-40%...
Earlier, in 2017, the drug pricing regulator had reduced the prices of stents by 87% and orthopaedic knee implants by invoking para 19 of Drugs Prices Control Order (DPCO) 2013 for a period of one year..
You might be interested in
Insacog meeting today to assess Covid situation as cases surge
06, Apr, 23India on Thursday reported 5,335 fresh Covid-19 cases, the highest single day rise since September 23, 2022, and a jump of nearly 1,000 cases from Wednesday's tally. According to data by the Union health ministry, the number active cases in the country went up by 2,496 on Thursday. XXB.1.16, a sub-lineage of Omicron, is accounting for about 60% of the total cases, a senior government official told ET.
India, US to jointly check spread of synthetic drugs
21, Jul, 23The US hosted the fourth annual meeting of the Counternarcotics Working Group (CNWG) with India.
Covid variant JN.1 spreading, but no rise in hospitalisations seen yet
29, Dec, 23India is experiencing a gradual increase in Coronavirus subvariant JN.1, with 162 confirmed cases so far, despite 798 new cases reported. The Indian SARS-CoV-2 Consortium on Genomics (Insacog) held a meeting to review the situation amid the spike in Covid-19 cases and decided to hold another meeting next week to understand the proportion of JN.1 and other sub-variants.
Rising COVID-19 cases in India: Union Health Minister urges states to conduct mock drill on April 10-11
07, Apr, 23The meeting comes on the day when the fresh COVID-19 cases in India stood at 6,050, the highest in 203 days.
Essential medicines including painkillers, antibiotics to get costlier by 12% from Saturday
28, Mar, 23Indias drug pricing authority on Monday allowed a price hike of 12.1218% from April 1 for scheduled drugs that are under price control. This will cover more than 800 drugs on the National List of Essential Medicines. Last year, the NPPA allowed a 10.7% increase in drug prices, citing a similar change in the WPI.
India home prices to rise 7% this year and next
05, Mar, 24Average home prices in India are set to rise 7% this year and next, driven by purchases of luxury properties. The housing market has powered along with Asia's No. 3 economy, facing challenges of stagnant wages, poverty, and a gap between demand and supply of affordable homes. Expectations of interest rate cuts should improve affordability.
Prices of 800 essential drugs to increase a tad from April 1
14, Mar, 24After massive annual increases of 12% and 10% in prices on record last year and in 2022, this will be a meagre increase for the pharma industry. The adjusted prices will cover more than 800 drugs on the National List of Essential Medicines. Price changes for scheduled drugs are allowed once a year.